Versant Venture Management, LLC Tempest Therapeutics, Inc. Put Options Transaction History
Versant Venture Management, LLC
- $56.3 Million
- Q2 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding TPST
# of Institutions
7Shares Held
846KCall Options Held
400Put Options Held
0-
Black Rock Inc. New York, NY550KShares$4.8 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ25.7KShares$224,5530.0% of portfolio
-
Cutler Group LP210Shares$1,8330.0% of portfolio
-
Cibc Private Wealth Group, LLC133Shares$1,1610.0% of portfolio
-
Jpmorgan Chase & CO New York, NY77Shares$6720.0% of portfolio
About Tempest Therapeutics, Inc.
- Ticker TPST
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,418,900
- Market Cap $91M
- Description
- Tempest Therapeutics Inc., a clinical-stage oncology company, engages in developing small molecule therapeutics to treat cancer. The company's two clinical programs are TPST-1495, a dual antagonist of EP2 and EP4, receptors of prostaglandin E2, and is currently in a Phase 1 trial in solid tumors; and TPST-1120, a selective antagonist of peroxiso...